619 related articles for article (PubMed ID: 19809997)
1. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients.
Serpa Neto A; Bianco Rossi FM; Dal Moro Amarante R; Alves Buriti N; Cunha Barbosa Saheb G; Rossi M
J Nephrol; 2009; 22(5):637-46. PubMed ID: 19809997
[TBL] [Abstract][Full Text] [Related]
2. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.
Navarro-Díaz M; Serra A; Romero R; Bonet J; Bayés B; Homs M; Pérez N; Bonal J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S213-7. PubMed ID: 17130264
[TBL] [Abstract][Full Text] [Related]
3. Percentage of excess BMI lost correlates better with improvement of metabolic syndrome after Roux-en-Y gastric bypass in morbidly obese subjects: anthropometric indexes and gastric bypass.
Rossi M; Serpa Neto A; Rossi FM; Amarante RD; Alcântara GC; da Silva RB; Regina PF
Surg Obes Relat Dis; 2009; 5(1):11-8. PubMed ID: 18996755
[TBL] [Abstract][Full Text] [Related]
4. The effect of gastric bypass surgery on hypertension in morbidly obese patients.
Carson JL; Ruddy ME; Duff AE; Holmes NJ; Cody RP; Brolin RE
Arch Intern Med; 1994 Jan; 154(2):193-200. PubMed ID: 8285814
[TBL] [Abstract][Full Text] [Related]
5. Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients: similar body weight loss, correction of comorbidities, and improvement of quality of life.
Suter M; Calmes JM; Paroz A; Romy S; Giusti V
Arch Surg; 2009 Apr; 144(4):312-8; discussion 318. PubMed ID: 19380643
[TBL] [Abstract][Full Text] [Related]
6. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
[TBL] [Abstract][Full Text] [Related]
7. Preoperative weight gain does not predict failure of weight loss or co-morbidity resolution of laparoscopic Roux-en-Y gastric bypass for morbid obesity.
Harnisch MC; Portenier DD; Pryor AD; Prince-Petersen R; Grant JP; DeMaria EJ
Surg Obes Relat Dis; 2008; 4(3):445-50. PubMed ID: 18501309
[TBL] [Abstract][Full Text] [Related]
8. Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer.
Couce ME; Cottam D; Esplen J; Schauer P; Burguera B
Obes Surg; 2006 Jul; 16(7):870-8. PubMed ID: 16839485
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass.
Moulin de Moraes CM; Mancini MC; de Melo ME; Figueiredo DA; Villares SM; Rascovski A; Zilberstein B; Halpern A
Obes Surg; 2005 Oct; 15(9):1287-91. PubMed ID: 16259889
[TBL] [Abstract][Full Text] [Related]
10. [Laparoscopic Roux-en-Y gastric bypass surgery for morbid obesity. Experience at the Nacional de Ciencias Médicas y Nutrición Salvador Zubirán].
Romero-Lbargüengoitia ME; Lerman-Garber I; Herrera-Hernández MF; Pablo-Pantoja J; Sierra-Salazar M; López-Rosales F; Zamora-Barrón M; Vargas-Martínez A; García-García E
Rev Invest Clin; 2009; 61(3):186-93. PubMed ID: 19736806
[TBL] [Abstract][Full Text] [Related]
11. Detailed description of early response of metabolic syndrome after laparoscopic Roux-en-Y gastric bypass.
Ali MR; Fuller WD; Rasmussen J
Surg Obes Relat Dis; 2009; 5(3):346-51. PubMed ID: 19362060
[TBL] [Abstract][Full Text] [Related]
12. Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein.
Agrawal V; Krause KR; Chengelis DL; Zalesin KC; Rocher LL; McCullough PA
Surg Obes Relat Dis; 2009; 5(1):20-6. PubMed ID: 18951068
[TBL] [Abstract][Full Text] [Related]
13. Improvement and stabilization of chronic kidney disease after gastric bypass.
Alexander JW; Goodman HR; Hawver LR; Cardi MA
Surg Obes Relat Dis; 2009; 5(2):237-41. PubMed ID: 18996757
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
Pereira JA; Lazarin MA; Pareja JC; de Souza A; Muscelli E
Obes Res; 2003 Dec; 11(12):1495-501. PubMed ID: 14694214
[TBL] [Abstract][Full Text] [Related]
15. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
[TBL] [Abstract][Full Text] [Related]
16. Circadian blood pressure variation in morbidly obese hypertensive patients undergoing gastric bypass surgery.
Czupryniak L; Strzelczyk J; Pawlowski M; Loba J
Am J Hypertens; 2005 Apr; 18(4 Pt 1):446-51. PubMed ID: 15831351
[TBL] [Abstract][Full Text] [Related]
17. Long-term changes in blood pressure in extremely obese patients who have undergone bariatric surgery.
Fernstrom JD; Courcoulas AP; Houck PR; Fernstrom MH
Arch Surg; 2006 Mar; 141(3):276-83. PubMed ID: 16549693
[TBL] [Abstract][Full Text] [Related]
18. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
[TBL] [Abstract][Full Text] [Related]
19. Five-year outcome with gastric bypass: Roux limb length makes a difference.
Gleysteen JJ
Surg Obes Relat Dis; 2009; 5(2):242-7; discussion 247-9. PubMed ID: 18996751
[TBL] [Abstract][Full Text] [Related]
20. Bariatric surgery in the treatment of obstructive sleep apnea in morbidly obese patients.
Fritscher LG; Canani S; Mottin CC; Fritscher CC; Berleze D; Chapman K; Chatkin JM
Respiration; 2007; 74(6):647-52. PubMed ID: 17728530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
